EverSource Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.96K | Buy |
103
+32
| +45% | +$921 | ﹤0.01% | 3348 |
|
|
2025
Q1 | $2.38K | Sell |
71
-16
| -18% | -$537 | ﹤0.01% | 2847 |
|
|
2024
Q4 | $4.45K | Buy |
87
+10
| +13% | +$511 | ﹤0.01% | 2405 |
|
|
2024
Q3 | $3.93K | Buy |
77
+10
| +15% | +$511 | ﹤0.01% | 2323 |
|
|
2024
Q2 | $3.56K | Buy |
67
+33
| +97% | +$1.75K | ﹤0.01% | 2340 |
|
|
2024
Q1 | $1.49K | Sell |
34
-85
| -71% | -$3.73K | ﹤0.01% | 2463 |
|
|
2023
Q4 | $4.23K | Buy |
119
+78
| +190% | +$2.78K | ﹤0.01% | 1920 |
|
|
2023
Q3 | $1.22K | Buy |
+41
| New | +$1.22K | ﹤0.01% | 2144 |
|